Connect to other sites within the UBM Medica Network
CancerLinQ: ASCO Dives Into Big Data
In this interview we discuss the American Society of Clinical Oncology’s (ASCO) health information and patient record initiative called CancerLinQ.
Relevance of pCR in Breast Cancer Trials
As part of our coverage of the ASCO Breast Cancer Symposium we discuss the clinical meaningfulness of pathologic complete response as a surrogate endpoint in breast cancer clinical trials.
Risk Modification Strategies for Breast Cancer
Ahead of the 2014 ASCO Breast Cancer Symposium we discussed genetic and environmental risk factors for breast cancer, as well as interventions that can reduce a patient’s risk.
Androgen Deprivation Therapy in Localized Prostate Cancer
Following studies that found no survival or mortality benefit, we discuss the utility of primary androgen deprivation therapy in localized prostate cancer.
Cervical Cancer Screening Guideline Update
In light of the recent FDA approval of HPV testing for women as a screening method for cervical cancer, we discuss changing guidelines with two experts.
ASCO: Treating BRCA-Positive Breast Cancer
As part of our coverage of the 2014 ASCO Annual Meeting, we discuss treatment strategies for breast cancer patients who harbor either the BRCA1 or BRCA2 mutation.
ASCO: Role of Chemotherapy and Novel Targeted Agents in Prostate Cancer
As part of our coverage of ASCO's Annual Meeting, we discuss the role of chemotherapy in prostate cancer, as well as study results on novel targeted approaches and agents in development for prostate cancer that will be presented at the meeting.
By clicking Accept, you agree to become a member of the UBM Medica Community.